The First Drug to Improve Survival in Liposarcoma.
Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch: daschenbrenner@ndm.edu.
Diane S
DS
Aschenbrenner
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005663:Furans / Q000627:therapeutic use*; D006801:Humans; D007659:Ketones / Q000627:therapeutic use*; D008080:Liposarcoma / Q000188:drug therapy*; D015996:Survival Rate; D014481:United States; D014486:United States Food and Drug Administration; D000095662:Polyether Polyketides
D000970:Antineoplastic Agents; D005663:Furans; D007659:Ketones; C490954:eribulin; D000095662:Polyether Polyketides